RTOG Foundation, Inc.

ACTIVE

50 S 16TH St Ste 2800, 宾夕法尼亚州费拉德尔菲亚县, Pennsylvania, United Stateswww.rtog.orgPrivate

Also known as:

radiation therapy oncology group

Clinical Trials

162

10 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

42.0%

Phase 3

38.3%

Phase 1

14.8%

Not Applicable

1.9%

Trial Status Distribution

Active, not recruiting

6.2%

Completed

139

85.8%

Recruiting

0.6%

Terminated

5.6%

Withdrawn

1.9%

Clinical Trials

Trials sponsored by this organization (162)

Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment

Phase 2

Recruiting

interventional

Aug 2025130 participants

A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery

Phase 2

Active, not recruiting

interventional

Apr 2019188 participants

SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma

Phase 2

Active, not recruiting

interventional

Nov 201886 participants

Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma

Phase 2

Terminated

interventional

May 20173 participants

Cisplatin and Etoposide Plus Radiation Followed By Nivolumab/Placebo For Locally Advanced NSCLC

Phase 3

Terminated

interventional

Oct 201620 participants

Safety Testing of Adding Nivolumab to Chemotherapy in Patients With Intermediate and High-Risk Local-Regionally Advanced Head and Neck Cancer

Phase 1

Completed

interventional

Jun 201640 participants

Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer

Phase 3

Active, not recruiting

interventional

Jan 2014330 participants

Radiation Therapy and Cisplatin With or Without Surgery in Treating Patients With Stage III-IV Oropharyngeal Cancer

Page 1 of 21

Approvals

No approval data available

News

No news articles found

Back to Organizations